Does serotonin reuptake inhibitor therapy increase the risk of post-sphincterotomy bleeding in patients undergoing endoscopic retrograde cholangio-pancreatography?

Table 7 Indications for endoscopic retrograde cholangiopancreatography

	Overall (n = 447)	SRI (n = 219)		No SRI (n = 228)	P value
	Summary		n (%)	n (%)
Abnormal CT	16 (3.8)		9 (4.3)	7 (3.3)	0.571
Abdominal pain	90 (21.2)		43 (20.6)	47 ( 21.9)	0.751
Abnormal LFT	62 (14.6)		32 (15.3)	30 (14.0)	0.691
Biliary dilation	8 (1.9)		6 (2.9)	2 (0.93)	0.172
Bile duct stones	187 (44.1)		96 (45.9)	91 (42.3)	0.451
Complications of prior biliary surgery	6 (1.4)		4 (1.9)	2 (0.93)	0.442
Jaundice	49 (11.6)		16 (7.7)	33 (15.3)	0.0131
Cholangitis	9 (2.1)	209	4 (1.9)	5 (2.3)	0.992

¹Pearson's χ² test;

²Fisher's exact test. Values presented as n (%). CT: Computed tomography; LFT: Lung function testing; SRI: Serotonin reuptake inhibitor.